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Murine ovarian folliculogenesis commences after birth involving oocyte growth, somatic cell differentiation and structural remodeling of
follicle stromal boundaries. The extracellular metalloproteinase ADAMTS-1 has activity against proteoglycans and collagen and is produced by
the granulosa cells of ovarian follicles. Mice with ADAMTS-1 gene disruption are subfertile due to an unknown mechanism resulting in severely
reduced ovulation. Here we show that ADAMTS-1 is necessary for structural remodeling during ovarian follicle growth. A significant reduction in
the number of healthy growing follicles and corresponding follicle dysmorphogenesis commencing at the stage of antrum formation was identified
in ADAMTS-1−/− ovaries. Morphological analysis and immunostaining of basement membrane components identified stages of follicle dysgenesis
from focal disruption in ECM integrity to complete loss of follicular structures. Cells expressing the thecal marker Cyp-17 were lost from dysgenic
regions, while oocytes and dispersed cells expressing the granulosa cell marker anti-mullerian hormone persisted in ovarian stroma. Furthermore,
we found that the ovarian lymphatic system develops coincidentally with follicular development in early postnatal life but is severely delayed in
ADAMTS-1−/− ovaries. These novel roles for ADAMTS-1 in structural maintenance of follicular basement membranes and lymphangiogenesis
provide new mechanistic understanding of folliculogenesis, fertility and disease.
© 2006 Elsevier Inc. All rights reserved.Keywords: Folliculogenesis; Extracellular matrix remodeling; Infertility; Lymphangiogenesis; ProteaseIntroduction
The mammalian ovarian follicle nurtures oocytes during their
development from quiescent primordial cells to fertilizable
maturity. The adult ovary is a unique organ that undergoes cyclic
tissue morphogenesis as follicles continually grow and ovulate
or regress. This process requires extensive tissue remodeling that
relies on the organized degradation and construction of extra-
cellular matrix (ECM) in the regions surrounding growing
follicles. Tissue morphogenesis during growth of ovarian folli-
cles involves restructuring the surrounding collagen rich stromal
ECM, the basement membrane that underlies the granulosa cell
layers and development of a vascular supply (Goldman and
Shalev, 2004; Hagglund et al., 2001; Smith et al., 2002). Quies-⁎ Corresponding author. Fax: +61 8 8303 4099.
E-mail address: Darryl.russell@adelaide.edu.au (D.L. Russell).
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doi:10.1016/j.ydbio.2006.10.012cent primordial follicles commence growth at random and
proliferating granulosa cells undergo up to 19 cell doublings as
follicles progress to preovulatory maturity. During this time the
structural integrity of the basement membrane and stromal ECM
is maintained while the follicular surface area expands up to
20,000-times (Rodgers et al., 1999).Most follicles never achieve
full developmental potential, instead they regress through
atresia, a well characterized process whereby granulosa cells
and oocytes initiate apoptosis, leukocytes invade and phagocy-
tose dead cells and debris resulting in complete destruction of the
follicle and oocyte (Wu et al., 2004).
The follicular basement membrane is composed of laminin
and collagen type IV, proteoglycans, nidogen and perlecan
(Rodgers et al., 2003) as well as versican (Russell et al., 2003b).
The basement membrane and stromal ECM surrounding
growing follicles function as a scaffold, filtration system and
extracellular signaling medium that controls the intrafollicular
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completed 3–4 doublings, a population of specialized stromal
cells known as thecal cells differentiates. The thecal layers
support neovascularization of the follicle (Vollmar et al., 2001)
and provide tensile structure, paracrine growth factor support
and steroidogenic activity for the growing follicle (Magoffin,
2005). While the theca, associated vasculature and basement
membrane are thought to modulate fluid dynamics during
formation of the follicular antrum (Isobe et al., 2005), neither the
developmental kinetics nor the role for ovarian lymphatics has
yet been investigated.
Proteases including matrix metalloproteinases (Curry and
Osteen, 2003) and the plasmin system (Beers et al., 1975;Mazaud
et al., 2005) are thought to be involved in remodeling the sur-
rounding ECM to maintain follicle integrity and function during
growth. However, gene ablation of these enzymes indicates that
they are not essential for folliculogenesis (Reviewed Curry). The
protease, a disintegrin and metalloproteinase with thrombospon-
din type 1 motifs-1 (ADAMTS-1), is a secreted extracellular
matrix (ECM)metalloprotease with catalytic activity against large
aggregating proteoglycans including versican and aggrecan
(Sandy et al., 2001). ADAMTS-1 has been identified in the
rodent ovary, the secreted active form selectively localizes to the
cumulus oocyte complex where it cleaves versican (Russell et al.,
2003a). Two alternative gene-targeting strategies used to knock-
out the ADAMTS-1 gene (Mittaz et al., 2004; Shindo et al., 2000)
each identified defects in female fertility arising from reduced
ovulation. Recently, reduced numbers of growing follicles,
aberrant follicular atresia and dysplasic ovarian vasculature
were reported in ADAMTS-1 null mice (Shozu et al., 2005). The
kinetics of follicle growth and regression were examined in detail
in this study. We confirm defective follicular growth dynamics in
the alternative ADAMTS-1 null mouse line and further character-
ize the kinetics of follicle growth and degeneration.Many follicles
of ADAMTS-1 null ovaries undergo unique structural dysmor-
phogenesis commencing at the first stages of antrum formation.
Dysgenic follicles undergo localized fracture of normal structural
matrix elements and eventually lose the granulosa cells and the
follicular structure surrounding oocytes. Surprisingly, oocytes and
sloughed granulosa cells persist in the ovarian stroma for long
periods resulting in increasingly severe dysplasia of ovarian
morphology as females age. Blood vasculature was assessed to be
present and similarly organized in normal and null ovaries, while
the establishment of a lymphatic network was severely delayed in
perinatal development of ADAMTS-1 null ovaries. The results
demonstrate a critical role for ADAMTS-1 in tissue matrix remo-
deling that sustains follicle growth. Furthermore, the postnatal
development of the draining lymphatic microvessel network of
the ovary and a vital role for the ADAMTS-1 gene in lymphan-
giogenesis is elucidated.
Materials and methods
Animal treatment and tissue preparation
The ADAMTS-1 null mutant mouse line in a 129SvJ/C57Bl6 genetic
background used in the present study was described previously (Mittaz et al.,
2004). Heterozygous crosses were maintained in 12 h light/dark and givenwater and rodent chow ad libitum. At weaning, offspring were genotyped
by PCR analysis of tail DNA samples as described previously (Mittaz et al.,
2004). Tissues were collected after cervical dislocation and immediately
fixed in 4% paraformaldehyde and processed for paraffin histology or snap
frozen for further analysis. ADAMTS-1 null mice were analyzed together
with matched littermate controls (wild type and/or heterozygous, as
indicated). All animals were treated in accordance with the Australian Code
of Practice for the care and use of animals for scientific purposes. Ethics
approval was obtained from The University of Adelaide Animal Ethics
Committee.
Ovaries, ear and dorsal skin were collected from immature 10 day or
21 day postnatal mice. Additional immature mice were IP-injected between
1300 and 1330 h on days 21–23 of age with 4IU PMSG (Professional Com-
pounding Centre of Australia, Sydney, NSW) to stimulate follicle develop-
ment. Ovaries were immediately fixed in 4% paraformaldehyde for 24 h, or
snap frozen for histology, immunohistochemistry, Western blot and TUNEL
assessments.
Protein extraction and Western blot
Total protein was extracted from whole ovaries of 2 (cycling animals), or
3 (day 10) independent animals by homogenization in proteoglycan extraction
buffer (50 mM Sodium acetate, 6 M Urea, 0.1% Triton buffer containing
1 mM EDTA; 1 mM PMSF, Leupeptin, Bestatin, Pepstatin A and Aprotinin
(Sigma, Perth, WA)). Homogenates were centrifuged for 5 min at 13200 rpm
and supernatant protein concentration measured by Bradford Assay (Bio-rad,
Sydney, Australia). Equal amounts (20 μg) of each protein sample along with
prestained protein Mwt markers (Bio-rad Laboratories, Sydney, NSW) was
subjected to electrophoresis in reducing 4–15% gradient polyacrylamide gels
(Bio-rad) and transferred onto polyvinylidene diflouride (PVDF) membranes
(Immobilon, Millipore). Membranes were blocked by 1 h RT incubation of
membrane in TBST (10 mM Tris [pH 7.5], 150 mM NaCl, 0.05% Tween-20)
containing 3% skim milk powder. Blots were then incubated with Lymphatic
Vessel Endothelial Hyaluronate Receptor 1 (Lyve-1) primary antibody (1/1000,
Chemicon Boronia Vic) for 1 h at RT in TBST+3% milk. After washing in
TBST, membranes were incubated (1 h, RT) with HRP-labeled goat anti-
rabbit secondary antibody (1/10,000 Amersham Biosciences, UK), washed
and enhanced chemiluminescence detection performed (Amersham Bios-
ciences, UK), according to manufacturer instructions. Chemiluminescence
was quantitated using Imagequant-ECL image capture and Imagequant TL
v2005 1-D gel electrophoresis band detection and analysis software (GE
Healthcare).
Immunohistochemistry
Tissue sections were dewaxed and rehydrated and antigen retrieval was
performed by incubating slides (20 min at 95°C) in citrate buffer solution
(10 mM sodium citrate, pH 6.0). Cooled, rinsed sections were incubated with
1 μg/mL Proteinase K (Sigma, Perth, WA) for 10 min at RT, then washed with
phosphate-buffered saline containing 0.025% Tween-20 (PBST, pH 7.4). Slides
were then blocked with 10% normal goat serum (NGS) in PBST for 1 h and
then incubated with primary antibodies O/N in a humid chamber, then washed
well with PBST and incubated with biotinylated secondary antibodies
(Chemicon) for 1 h. After further washing, sections were incubated with
fluorescent probes, Strepdavidin-Alexa488, Strepdavidin-Alexa594 or Anti-
Rabbit IgG-Alexa488 (1/500, Molecular Probes Eugene Oregon, USA). Sections
were counterstained with 4′,6-diamidino-2-phenylindole dihydrochloride
(DAPI) (Molecular Probes) and mounted under coverslips with fluorescent
mounting media (DAKO, Carpenteria, CA). Alternatively, sections were treated
with Strepdavidin horseradish peroxidase (HRP) conjugate (Vectastain ABCKit,
Vector Laboratories, Burlingame, CA) and detection was performed using
diaminobenzadine (Vector) according to manufacturer's instructions. Light or
fluorescence microscopy was observed on an Olympus BX50 microscope
(Olympus, Australia, Pty. Ltd.) and photographed with a SPOT camera and
SPOT-Advanced software (Version 4.0.4, Diagnostic Instruments, Sterling
Heights, MI). The primary antibodies used were as follows; polyclonal rabbit
anti-mouse ADAMTS-1 1/750 (Russell et al., 2003a) and anti-17-α-hydroxylase
(Cyp-17) 1/1000 (Conley et al., 1992). Commercial polyclonal rabbit anti-mouse
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bodies were purchased from Chemicon (Boronia, VIC). Goat anti-mouse anti-
mullerian hormone (AMH) antibody was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Secondary antibodies (biotinylated goat-anti-
rabbit, rabbit-anti-goat, donkey-anti-goat) were purchased form Chemicon
(Boronia, VIC). Anti-rabbit IgG Alexa488 and Strepdavidin labeled Alexa488 and
Alexa594-labeled fluorophores were purchased from Molecular Probes (Eugene,
OR). Normal sera were purchased from Vector Laboratories (Burlingame, CA).
Negative controls included incubation with species and isotyped matched non-
specific primary antibodies.
TUNEL labeling of apoptotic cells
A terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end
labeling (TUNEL) was performed as previously described (Clark et al.,
2004). Briefly, 7 μm sections were dewaxed and rehydrated then washed in
PBS (10 mM Na2HPO4, 10 mM KH2PO4, 317 mM NaCl, 5 mM KCl).
Sections were incubated with proteinase K (5 μg/mL in 50 mM Tris–HCl,
5 mM EDTA) for 45 min at 37°C and incubated with 0.5 nM biotin-16-2′-
deoxy-uridine-5′-triphosphate, 50 U/mL terminal transferase (Roche Diag-
nostics GmbH) and 1.5 mM cobalt chloride in reaction buffer (30 mM
Tris–HCl, pH 7.2, 140 mM sodium cacodylate) for 1 h at 37°C. Sections
were washed in PBS then incubated with Strepdavidin-Alexa594 (1:500) for
1 h at RT, counterstained with DAPI and mounted under coverslips for
imaging.
Morphometric analysis
Paraffin embedded 7 μm sections were dewaxed, rehydrated and stained with
hematoxylin and eosin (Sigma). Images of whole ovary sections were captured at
4× magnification, as well as of each follicle at 20× magnification, in every 5th
section. Follicles containing an oocyte in the plane of section were counted in
every 5th section throughout ovaries and classified as either healthy follicles of
developmental types 4–8, in accordance with the established mouse ovarian
follicle classification system (Pedersen and Peters, 1968), or dysgenic stages 1–4
as described in Results. Numbers of type 7 and type 8 follicles were combined
because the observation of a cumulus stalk that defines stage 8 was rare in normal
and null ovaries. Poly-ovular follicles, those containing more than one oocyte,
were also recorded. Atretic follicles were classified using recognized indicators
of atresia including: pyknotic nuclei in the granulosa cells, cell debris in the
antrum, angular or non-round follicle shape, flattened or angular oocyte shape,
collapsed zona pelucida, granular or fragmented cytoplasm (Kaipia and Hsueh,
1997).
Statistics
Follicle scoring data were analyzed as mean number of follicles per ovary,
n=4–5 ovaries per group and expressed as mean±SEM. Statistical significance
in follicle counts and Lyve-1 Western blots was analyzed using unpaired
Student's t-test and was deemed significant if P≤0.05. All observations were
based on a minimum of 4 independent animals and at least 3 independently
repeated experiments.Results
Disrupted structural morphogenesis of developing
ADAMTS-1−/− ovarian follicles
Histological analysis of ovaries collected from immature
(21–23 day old) mice or following a 48 h PMSG stimulation
(23–25 day old) revealed a failure in the normal follicle deve-
lopment process. Follicles entering the transition to antral stage
frequently showed altered tissue structure and cellular
organization at the boundary between theca and granulosacells (Figs. 1a–b, arrowheads). Additionally, large numbers of
follicle-like structures were observed containing morphologi-
cally normal oocytes surrounded by disorganized and fre-
quently uneven layers of granulosa cells with no apparent
thecal tissue compartment (Fig. 1c). Finally, a large number of
intact oocytes were observed surrounded by ovarian stroma
with no granulosa or thecal compartments identifiable.
To more fully describe and characterize follicle dysgenesis,
we developed a four-stage classification system and used this
to facilitate scoring of the dysgenic follicle numbers in
comparison to the normal healthy and atretic follicles present
in ovaries. Through detailed observations of ADAMTS-1 null
ovaries, we characterized dysgenic stages of folliculogenesis as
follows. Stage 1 follicles usually in the preantral to antral tran-
sition phase of growth appear morphologically normal except
for sporadic deformity in the granulosa or thecal structure and
loss of the uniform pattern of theca/mural granulosa cell
morphology (Fig. 1a). Oocytes were often acentrically located
in the follicle and in direct contact with the basement membrane
if present, or thecal boundary. Stage 2 was identified as more
advanced follicular dysmorphogenesis, oocytes surrounded by
many disorganized granulosa layers, yet contain no antrum and
little or no identifiable basement membrane or thecal tissue (Fig.
1b). Stage 3 was identified as no recognizable theca present,
granulosa cells layers uneven and do not fully enclose the
oocyte (Fig. 1c). Stage 4 was identified as no morphologically
identifiable follicle structure around intact oocytes which
appear “orphaned” in the ovarian stroma (Fig. 1d). In cycling
animals, large numbers of follicles in stage 4 of dysgenesis
populate ADAMTS-1−/− ovarian stroma and poly-ovular folli-
cles were unusually frequent compared with littermate controls
(Fig. 1e, arrows, and Table 1) We found abundant pro-
ADAMTS-1 protein in healthy follicles of WT mice at the
preantral to antral transition phase by immunohistochemistry
(Fig. 1f).
Numbers of healthy growing follicles, follicles with each
stage of dysgenic appearance and those with normal atretic
appearance counted in serial sections of ovaries are shown in
Table 1. In this analysis, immature 23 day old PMSG treated
(48 h) mice were used to ensure that hormonal support for
follicle growth was equivalent in control and null groups and
that a range of follicles up to late preovulatory stage (type 7/
8) were present. Healthy preantral follicles of type 4–5b were
equally represented in controls or ADAMTS-1−/− ovaries.
However, a significant 25% reduction in type 6 follicles (first
antral stage) was observed in ADAMTS-1−/− compared to
littermate control ovaries. Consistent with this, a significant
30% decrease in the number of large preovulatory (type 7/8)
follicles was also identified in ADAMTS-1−/− compared to
control ovaries. Correspondingly, ADAMTS-1−/− ovaries
contained a significant increase in follicles of dysgenic stages
1, 3 and 4. Stage 2 dysgenic follicles were more rarely identified
but showed a trend toward increase that was not statistically
significant (P=0.052). Ovaries of ADAMTS-1 null mice also
contained follicles undergoing classical atresia. These were
identifiable as a separate cohort to the dysgenic follicles des-
cribed here and were present in equivalent numbers in null and
Fig. 1. Ovarian follicular dysgenesis in ADAMTS-1−/− mice. Sections of ovary from immature mice were stained with hematoxylin and eosin and four stages of
follicular dysgenesis described. (a) Stage 1; arrowhead indicates focal loss of theca cell organization and basement membrane structure of a type 5b follicle. (b) Stage 2
dysgenenic follicle with regions of complete absence of thecal tissue and multiple non-uniform granulosa cell layers. Arrowhead indicates region of normal
organization of the thecal-granulosa boundary. (c) Stage 3 dysgenic follicle with no typical follicular structure, some morphological granulosa-like cells remain loosely
associated with the oocyte. Arrows indicate granulosa cells. (d) Stage 4 dysgenic follicle or “orphaned” oocyte surrounded by ovarian stroma and vasculature. (e)
Mature cycling adult ovary showing multiple stage 4 dysgenic follicles (arrowheads) and poly-ovular follicles (arrows). (f) Immunohistochemical demonstration of
active ADAMTS-1 in a type 4 follicle. Scale bars=100 μm.
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was significantly higher in ADAMTS-1−/− ovaries and this
increase could be accounted for by the presence of the dysgenicTable 1
Number of follicles per ovary wild type vs. ADAMTS-1−/−
Follicle classification
Type 4 Type 5a Type 5b Ty
WT 13.8±2.22 5.6±0.81 0.8±0.37 4
KO 12.25±2.53 4.25±0.63 0.75±0.48
Dysgenic follicle classification
Stage 1 Stage 2 Stage 3 Sta
WT 3.00±0.71 0 0.20±0.20
KO 21.00±6.42 ⁎ 1.75±0.85 2.50±0.87 ⁎ 64
Wild-type (WT), n=5; ADAMTS-1−/− (KO), n=4.
Data are presented as mean±SEM.
* Significantly different from WT P<0.05, unpaired t-test.follicles (Table 1), suggesting that these follicles are not as
rapidly cleared from the ovary as follicles regressing by the
normal atretic pathway.pe 6 Type 7/8 Atretic Poly-ovular
6.8±3.12 34.8±1.53 71±6.98 0
28±4.14 ⁎ 20.75±6.41 ⁎ 72.25±8.67 3.75±1.80 ⁎
ge 4
0
.75±8.23 ⁎
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ADAMTS-1−/− ovarian stroma
To determine the fate of follicular somatic cells that are lost
during dysmorphogenesis of ADAMTS-1−/− follicles, we
performed immunofluorescent staining for anti-Mullerian hor-
mone (AMH), a granulosa specific marker, as well as 17-alpha-
hydroxylase (Cyp-17), a theca cell marker. This and all
subsequent analyses were performed in ovaries of 10 day and
21 day old pre-pubertal mice, which allowed us to observe large
numbers of synchronized follicles transitioning through pre-
antral to antral stages during the first postnatal follicular growth
wave. As expected, in control heterozygous and WT ovaries,
AMH immunopositive cells were found only within intact and
non-atretic follicular structures. Co-staining for collagen-IV
elucidated the basement membrane and distinct granulosa-thecal
boundary showing AMH staining restricted to granulosa cells
surrounded by the basal lamina in normal ovaries (Figs. 2a–c).
In ADAMTS-1 null ovaries, dysgenic follicles with atypical
structure were identified with inappropriate organization of
AMH and collagen-IV (Figs. 2d–i, arrows), or with complete
loss of basement membrane integrity (Figs. 2j–l). Additionally,
AMH positive cells were abnormally distributed throughout the
ovarian stroma, not associated with any follicular structure nor
encased by a basement membrane as normally expected (Figs.
2d–f, arrowheads). Oocytes with no normal surrounding
follicular structure were identified that showed some remaining
associated AMH positive granulosa cells loosely encased by
basement membrane remnants (Figs. 2j–l, arrowheads), indicat-
ing that these oocytes indeed originated in organized follicles
that subsequently degenerated.
Theca cells expressing the steroidogenic enzyme P450
Cyp-17 were identified in large numbers around growing
follicles of type 4–8 in day 21 control ADAMTS-1+/− ovaries
(Fig. 2m). While follicles of ADAMTS-1−/− ovaries with stage
1 or 2 dysmorphogenesis showed strikingly disorganized or
entirely absent Cyp-17 staining (Fig. 2n, arrow), no Cyp-17
staining was evident around follicles or oocytes of stages 3–4
dysgenic structural appearance.
Follicular basement membrane structural remodeling is
disrupted in ADAMTS-1−/− ovaries
To further determine whether structural components that
organize cellular compartments during folliculogenesis are
inappropriately remodeled during the process of follicle
dysgenesis, we analyzed the abundance and localization of
basement membrane structural proteins in ADAMTS-1 null
ovaries. Laminin α1 immunohistochemistry in day 10 and day
21 postnatal ovaries identified a continuous discrete basement
membrane surrounding all follicles from primordial to pre-
ovulatory in control mice (Fig. 3a). Laminin α1 staining
structures identified in the ovarian stroma were mostly asso-
ciated with vasculature or primordial follicles. In ADAMTS-1−/−
mice, laminin-α1 immunolocalization frequently demonstrated
basal lamina only partially surrounding follicle structures.
Laminin α1 was discontinuous around follicles with morpho-logical signs consistent with stage 1 dysgenesis in either 10 or
21 day old mice (Fig. 3b and e, respectively). Some abnormal
laminin deposition in the ovarian stroma was also evident.
Similar changes in basement membrane integrity and structure
were seen with collagen-IV immunofluorescent staining (Fig.
3g). Dysgenic follicles were identified with disorganized
collagen-IV staining ranging from incomplete to entirely absent.
Remnants of the follicular basal lamina could be observed
encapsulating granulosa cells becoming detached from the
oocyte (Figs. 2l and 3g).
There was no apparent difference in the amount or
localization of apoptotic cell death in ovaries from control or
ADAMTS-1 null mice, as determined by terminal-deoxynucleo-
tidyl-transferase mediated dUTP-biotin nick end-labeling
(TUNEL), either inside follicles or in the stromal compartment
(data not shown).
Disrupted lymphangiogenesis in ADAMTS-1 null ovaries
Previously ADAMTS-1 null ovaries were reported to have
excessive layers of microvasculature around developing follicles
as well as reduced vascular volume in the ovarian medullar
region (Shozu et al., 2005). To further examine the possibility of
aberrant development of the vascular system, we assessed
lymphatic structures using the lymphatic endothelial marker
Lyve-1. In normal mice, large numbers of vessels with positive
Lyve-1 staining were found associated with follicles from type 5
developmental stage onwards, irrespective of mouse age (Fig. 4,
arrowheads). Immature ADAMTS-1−/− ovaries from postnatal
day 10 and day 21 mice had greatly reduced lymphatic vessel
numbers compared to littermate control ovaries. No Lyve-1
positive vessels were identified in n=6 postnatal day 10 or day
21 ADAMTS-1 null mouse ovaries, despite strongly Lyve-1
positive vessels being evident in extra-ovarian fat tissue (Fig. 4,
arrows). Lyve-1 positive lymphatic vessels were detected in
ovaries of adult cycling ADAMTS-1−/− mice or immature mice
after treatment on day 21 with PMSG (48 h) to stimulate follicle
growth (not shown). QuantitatedWestern blot analysis indicated
that the proportion of Lyve-1 abundance was reduced in ovaries
of ADAMTS-1−/− (light bars) mice on day 10 as well as cycling
mice compared to ADAMTS-1+/− littermates (dark bars, Fig. 4e
histogram). Lyve-1 abundance was consistently lower in null
ovary samples; however, this was found to be significant in
cycling but not day 10 ovaries due to large variance in the
amount of Lyve-1 detectable in day 10 ovaries, possibly due to
varying amounts of development at this stage. In livers of day 10
mice, Lyve-1 was equally abundant in control and null
littermates (Fig. 4e histogram). We subsequently examined
dermal lymphatic vessel formation by immunofluorescence in
back and ear skin of day 10 and 21 mice and found that Lyve-1
positive vessels appeared fully formed in these cutaneous tissues
of ADAMTS-1−/− mice (Fig. 5).
Discussion
Continual cyclic phases of follicle growth, ovulation and
regression challenge the mammalian ovary to maintain constant,
Fig. 2. Identification of granulosa and thecal cell markers in ADAMTS-1−/− ovaries. Immunofluorescent localization of anti-mullerian hormone (AMH; a–l red), and
collagen-IV (a–l, green) or CYP-17 (m, n, red). Collagen-IV staining delineates intact follicular basement membranes in ADAMTS-1+/− control ovaries (a, c) and
demonstrates severe disorganization of basement membrane structure in ADAMTS-1−/− dysgenic follicles of stages 1–2 (d–i, arrows). The circumference of stage 3
dysgenic follicles was devoid of any organized basement membrane (g–h). Scattered cells throughout ovarian stroma stained positive for AMH (d–f), or fragmentary
collagen-IV stained basement membrane encapsulates AMH positive granulosa cells becoming detached from the oocyte (j–k). Images a–l taken at 60× original
magnification, scale bar=100 μM. Immunostaining of CYP-17 identifies thecal cells around type 5–8 growing follicles in ADAMTS-1+/− mice (m). In ADAMTS-1−/−
dysgenic follicles (arrowheads), no CYP-17 staining is present. Images m and n taken at 20× original magnification.
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Fig. 3. Loss of follicular extracellular matrix components in ADAMTS-1−/− ovaries. Laminin (a–e) and collagen-IV (f, g) immunofluorescent labeling of basement
membrane structure in 10 and 21 day postnatal control (a, d, f) and ADAMTS-1−/− (b, c, e, g) ovaries. Laminin and collagen-IV surround the entire follicle
circumference of healthy growing follicles in ADAMTS-1+/− ovaries. Laminin is frequently discontinuous (b, e, arrowheads) or aberrantly thickened (c, arrow) in stage
1 or 2 dysmorphogenic ADAMTS-1−/− follicles. Collagen-IV is found mainly in basement membranes of follicles and blood vasculature in ADAMTS-1+/− controls (f).
Strikingly disorganized and fragmented collagen-IV positive basement membrane associated with dysgenic follicles continues to underlie the boundary between
remaining granulosa cells and stromal tissue (g, red arrow). All images taken at 60× original magnification, scale bar=100 μM.
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The present study indicates that structural morphogenesis of
follicles and the ovarian stroma requires ADAMTS-1 from the
first postnatal wave of folliculogenesis throughout reproductive
life. We observed a pattern of follicular degradation in
ADAMTS-1 null mice ranging from minor loss of structural
integrity to complete degeneration of the follicular environment
that results in intact “orphaned” oocytes of healthy appearance
surrounded by ovarian stroma. This latter morphology was
confirmed during preparation of this manuscript in another
ADAMTS-1−/− strain by Shozu et al. (2005) who proposed a
process of aberrant atresia; however, the etiology of this pheno-
type was not determined. A significant reduction of healthy early
antral and preovulatory follicles, but not preantral follicles in the
ADAMTS-1 null ovaries was found in our study and was also
consistent with results of Shozu et al. (2005). Together these
phenotypic abnormalities suggest that degeneration begins in
type 6 follicles concomitant with antrum formation.
Very rapid expansion of the follicle surface area is required
during growth of antral follicles. Our calculations estimate thefollicle surface area increases over 500 times in the mouse
(surface area increases from 1256 μm2 in primordial to
785,398 μm2 in preovulatory follicles), similar to estimations
in bovine (Rodgers et al., 1999). We show here that ADAMTS-
1 is present in granulosa cells of type 5–6 follicles, while
ovaries with ADAMTS-1 gene ablation contained non-atretic
type 5–6 follicles with discontinuous or disorganized basal
collagen-IV and laminin-α1. Thus deficiency in ADAMTS-1
results in the inability of growing follicles to restructure ECM
components of the follicle and stromal environments, and
diminished capability to maintain rapid volumetric expansion
during antral follicle growth. Since the increase in dysgenic
follicles was coincident with reduced healthy antral stage
follicles while atretic follicle numbers were unaltered, it can be
concluded that follicles in the growing pool are those that
undergo dysmorphogenesis. Remodeling of follicular basement
membrane components therefore requires ADAMTS-1 that is
critical for late stage follicle development. Interestingly, some
follicles in ADAMTS-1 nulls succeed in developing to maturity
and indeed ovulate (Mittaz et al., 2004). This is likely due to
Fig. 5. Lymphatic vessels are formed in skin of ADAMTS-1−/−mice. Lymphatic endothelial marker Lyve-1 immunofluorescent staining (green) of back skin, cell nuclei
counterstained with DAPI (blue). Fully formed lymphatic vessels were identified associated with hair follicles of day 10 postnatal ADAMTS-1+/− (a) or ADAMTS-1−/−
(b) mice. Original magnification 40×, scale bar=100 μM.
Fig. 4. Lymphatic vessels staining positive for Lyve-1 are absent from immature ADAMTS-1−/− ovaries. Immunofluorescent staining of Lyve-1 (a, b red; c, d green)
positive lymphatic endothelial cells detects fully formed vessel networks in 10 and 21 day postnatal ADAMTS-1+/− ovaries (a, c, arrowheads). No Lyve-1 positive
vessels were detectable in six ADAMTS-1−/− ovaries at either developmental stage (b, d), despite Lyve-1 positive vessels being strongly detected in extra-ovarian fat of
the same tissue sections (b, d, arrows). Cell nuclei were counterstained with DAPI (blue), images taken at 20× original magnification, scale bar=50 μM. (e) Western
blot of Lyve-1 in extracts pooled from 3 independent 10-day old, 2 independent cycling adult ovaries, or individual livers of ADAMTS-1+/− or ADAMTS-1−/− mice.
Upper panel shows an example of Western blot results. Lower bar graph shows quantitated band intensities from three pools of three day-10 ovaries, five pools of 2
cycling ovaries or four individual liver extracts of each genotype (light bars, ADAMTS-1+/−; dark bars, ADAMTS-1−/−, numbers in each bar indicate the number of
independent replicate samples assessed). Molecular weight marker sizes (kDa) are indicated to the right of the Western blot, *P<0.05 Student's t-test.
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(Richards, 2005; Russell et al., 2003a). We propose that these
follicles originate from a slower-growing cohort capable of
remodeling their thecal/basement membrane ECM structure
through redundant or compatible mechanisms. Consistent with
this, groupings of follicles with slow vs. rapid developmental
kinetics have been previously proposed based on ultrastructural
observations of the follicular basement membrane (Irving-
Rodgers et al., 2002) where slower growing follicles have
basement membranes with a folded structure apparently being
expanded in advance of follicular growth.
The mechanisms by which ADAMTS-1 mediates ECM
remodeling most likely involve enzymatic metalloproteinase
activity. Active ADAMTS-1 is secreted and degrades ECM
proteins including lecticans (aggrecan, brevican and versican)
(Sandy et al., 2001). In ovulating follicles, we previously
showed that secreted ADAMTS-1 localizes through ECM
binding to the cumulus oocyte complex where it is essential
for versican processing in the matrix that surrounds oocytes
(Russell et al., 2003a). We and others have also shown that
versican is present in growing follicles throughout develop-
mental stages and is either a component of, or closely associated
with the follicular basement membrane (McArthur et al., 2000;
Russell et al., 2003b). Thus processing of versican by
ADAMTS-1 may be requisite for the basement membrane or
thecal ECM remodeling and maintenance of structural organiza-
tion of follicles. Recently it has been determined that ADAMTS-
1 also possesses gelatinase activity (Lind et al., 2006). Active
gelatinases have long been supposed to be required for the
remodeling of collagen-IV and laminin in developing basement
membranes (Mazaud et al., 2005; Vu and Werb, 2000). The
classical gelatinases MMP-2 and MMP-9 are expressed during
follicle development (Curry and Osteen, 2003) but null
mutations of either enzyme have no effect on fertility (Itoh et
al., 1999; Vu et al., 1998) or ovarian developmental dynamics
(Russell DL and Richards JS unpublished). Our present results
suggest that ADAMTS-1 is important for controlled remodeling
of laminin and collagen and follicular basement membrane
expansion. This is further supported by observations of
increased renal collagen-IV expression and interstitial matrix
thickening in 6–12 month old ADAMTS-1−/− kidneys (Mittaz
et al., 2005) and demonstrates a possible common role in
organogenesis.
Loss of the follicular basement membrane structure due to
ADAMTS-1 deficiency impacts on the normal separation of the
epithelial–mesenchymal boundary. In ADAMTS-1−/− ovaries,
the epithelial granulosa cells lost their normal organization, but
many of these cells maintained granulosa-like cell specification
as evidenced by abundant AMH staining cells present in the
ovarian stroma. This maintenance of cell specification was
surprising in the absence of normal structural and ECM cues
including the absence of the basement membrane upon which
granulosa cell specification is thought to depend (Amsterdam et
al., 1989; Luck, 1994). Transdifferentiated granulosa cells and
testis-like structures, such as observed in estrogen deficient
mouse models (Britt et al., 2002; Couse et al., 1999), were never
observed, further indicating that the loss of follicular structureresults from inadequate tissue ECM remodeling rather than
failure to maintain granulosa cell specification or steroidogen-
esis. Cells expressing the thecal lineage marker Cyp-17 were
rapidly lost from the dysgenic follicles. In stage 1 dysgenic
follicles thecal tissue organization was disrupted in the region of
focal basement membrane degradation, indicating that the
specification or maintenance of these specialized mesenchymal
cells may depend on extracellular structural cues. Theca derived
cells are likewise unable to maintain their gene expression
profile in vitro (Rainey et al., 1996), thus it is accepted that these
cells require in vivo regulatory cues to retain their differentiated
phenotype (Magoffin, 2005). The appearance of significantly
greater numbers of poly-ovular follicles is commonly associated
with insufficiency of the theca or follicular boundary (Hahn et
al., 2005). This phenotype in ADAMTS-1 null mice further
indicates that the theca and/or ECM of the follicular boundary
are affected early in the process of follicle degradation.
Our data show that ADAMTS-1 may have a previously
unidentified role in lymphangiogenesis. Development of the
ovarian lymphatic system was severely delayed in ADAMTS-1
null mice. The normal kinetics of ovarian lymphangiogenesis
was found to occur entirely during postnatal life, with the first
appearance of Lyve-1 positive vessels between days 7 and 10
corresponding with the development of secondary follicles
(types 5–6) in the first wave of folliculogenesis. This timing
also correlates with the first differentiation of thecal cells which
support blood vascularization of the follicle (Vollmar et al.,
2001). Our assessment of the proportion of Lyve-1 positive cells
by Western blot indicated that the lymphatic system remains
deficient in ADAMTS-1−/− adult ovaries. Lymphatic vessels
develop from endothelial cell buds that proliferate and migrate
from veins (Wigle and Oliver, 1999). Therefore, ADAMTS-1
activity may be important for lymphatic endothelial cell
adhesion, migration or invasion of ovarian ECM. ADAMTS-1
has been found to bind and inactivate VEGF-A and FGF-2
controlling blood vessel angiogenesis (Iruela-Arispe et al.,
2003) and increased blood vasculature was reported surround-
ing antral follicles in another ADAMTS-1 null mouse line
(Shozu et al., 2005). Hence the possibility exists that
ADAMTS-1 modulates the balance of ovarian blood and lym-
phatic angiogenic processes around ovarian follicles through
interaction with these growth factors.
The failure to establish a follicular lymphatic bed in the
absence of ADAMTS-1 may be either a cause of follicular
dysgenesis or a consequence. Importantly, the role of lymphatic
vessels in the ovary remains to be determined. It is conceivable
that lymphatics contribute to the dynamics of follicular antral
fluid collection since a primary role for the lymphatic system
is to drain extravascular fluid from tissues. The absence of
draining lymphatics in the ovary is expected to result in excess
intercellular fluid and increased tissue pressure which may have
a negative impact on follicle growth and remodeling. Interest-
ingly, one study over 25 years ago reported that infertility and
gonadal dysgenesis in women of normal karyotype are
commonly associated with lymphatic hypoplasia of the lower
extremities (Vittay et al., 1980). In several human diseases,
lymphedema is also exacerbated by puberty (Wright and Carty,
708 H.M. Brown et al. / Developmental Biology 300 (2006) 699–7091994) suggesting a direct association of gonadal and lymphatic
development in humans. In the ADAMTS-1 null mouse model
puberty or exogenous PMSG treatment enhanced the formation
of ovarian lymphatics. Our results indicate that ovarian
lymphangiogenesis may be uniquely hormonally regulated and
that ovarian follicular development indeed involves the forma-
tion of a lymphatic network. Such hormonal regulation of the
ovarian lymphatic network may contribute to other conditions
such as ovarian hyperstimulation syndrome, whereby exogen-
ous hormone treatment during assisted reproductive therapy
may alter the balance between vascular permeability and
lymphatic drainage in some women resulting in dangerous
accumulation of fluid in the peritoneum (Budev et al., 2005).
The normal regulation of ovarian lymphangiogenesis and that in
ovaries of women who respond to hormonal stimulus in this way
needs further investigation.
In conclusion, this investigation of female infertility in
ADAMTS-1−/− mice indicates that this extracellular protease has
a non-redundant critical role in normal folliculogenesis as well
as lymphangiogenesis in the developing ovary. Remodeling of
follicular basement membrane components around growing
follicles is dependent on the action of ADAMTS-1, indicating
that this enzyme activity is important for tissue morphogenesis
in developing organ structures. Infertility in ADAMTS-1 null
mice thus results at least in part from an early defect in follicle
growth. Further studies will extend this to determine whether
partial perinatal lethality in ADAMTS-1 null mice may result
from insufficiency in similar ECM remodeling processes of
other developing organs. The identified requirement for
ADAMTS-1 during ovarian lymphangiogenesis adds an inter-
esting new perspective to the emerging role for this enzyme in
regulating blood angiogenesis and may indicate a reciprocal
relationship between development of blood and lymphatic
networks. Importantly our findings suggest a mechanistic link
between ADAMTS-1, lymphangiogenesis and fertility.
Acknowledgments
The authors thank Dr. Alan Conley for generously providing
the anti-Cyp-17 antibody, and Dr. Ray Rodgers and Dr. Natasha
Harvey for expert opinion and discussion throughout these
studies. This work was supported by the National Health and
Medical Research Council of Australia.
References
Amsterdam, A., Rotmensch, S., Ben-Ze'ev, A., 1989. Coordinated regulation of
morphological and biochemical differentiation in a steroidogenic cell: the
granulosa cell model. Trends Biochem. Sci. 14, 377–382.
Beers, W.H., Strickland, S., Reich, E., 1975. Ovarian plasminogen activator:
relationship to ovulation and hormonal regulation. Cell 6, 387–394.
Britt, K.L., Kerr, J., O'Donnell, L., Jones, M.E., Drummond, A.E., Davis, S.R.,
Simpson, E.R., Findlay, J.K., 2002. Estrogen regulates development of the
somatic cell phenotype in the eutherian ovary. FASEB J. 16, 1389–1397.
Budev, M.M., Arroliga, A.C., Falcone, T., 2005. Ovarian hyperstimulation
syndrome. Crit. Care Med. 33, S301–S306.
Clark, L.J., Irving-Rodgers, H.F., Dharmarajan, A.M., Rodgers, R.J., 2004.
Theca interna: the other side of bovine follicular atresia. Biol. Reprod.
1071–1078.Conley, A.J., Head, J.R., Stirling, D.T., Mason, J.I., 1992. Expression of
steroidogenic enzymes in the bovine placenta and fetal adrenal glands
throughout gestation. Endocrinology 130, 2641–2650.
Couse, J.F., Hewitt, S.C., Bunch, D.O., Sar, M., Walker, V.R., Davis, B.J.,
Korach, K.S., 1999. Postnatal sex reversal of the ovaries in mice lacking
estrogen receptors alpha and beta. Science 286, 2328–2331.
Curry Jr., T.E., Osteen, K.G., 2003. The matrix metalloproteinase system:
changes, regulation, and impact throughout the ovarian and uterine
reproductive cycle. Endocr. Rev. 24, 428–465.
Goldman, S., Shalev, E., 2004. MMPS and TIMPS in ovarian physiology and
pathophysiology. Front. Biosci. 9, 2474–2483.
Hagglund, A.C., Basset, P., Ny, T., 2001. Stromelysin-3 is induced in mouse
ovarian follicles undergoing hormonally controlled apoptosis, but this
metalloproteinase is not required for follicular atresia. Biol. Reprod. 64,
457–463.
Hahn, K.L., Johnson, J., Beres, B.J., Howard, S., Wilson-Rawls, J., 2005.
Lunatic fringe null female mice are infertile due to defects in meiotic
maturation. Development 132, 817–828.
Iruela-Arispe, M.L., Carpizo, D., Luque, A., 2003. ADAMTS1: a matrix
metalloprotease with angioinhibitory properties. Ann. N. Y. Acad. Sci.
183–190.
Irving-Rodgers, H.F., Mussard, M.L., Kinder, J.E., Rodgers, R.J., 2002.
Composition and morphology of the follicular basal lamina during atresia
of bovine antral follicles. Reproduction 123, 97–106.
Isobe, N., Kitabayashi, M., Yoshimura, Y., 2005. Microvascular distribution and
vascular endothelial growth factor expression in bovine cystic follicles.
Domest. Anim. Endocrinol. 29, 634–645.
Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R.,
Uehira, M., 1999. Experimental metastasis is suppressed in MMP-9-
deficient mice. Clin. Exp. Metastasis 17, 177–181.
Kaipia, A., Hsueh, A.J., 1997. Regulation of ovarian follicle atresia. Annu. Rev.
Physiol. 59, 349–363.
Lind, T., Birch, M.A., McKie, N., 2006. Purification of an insect derived
recombinant human ADAMTS-1 reveals novel gelatin (type I collagen)
degrading activities. Mol. Cell. Biochem. 281, 95–102.
Luck, M.R., 1994. The gonadal extracellular matrix. Oxford Rev. Reprod. Biol.
16, 33–85.
Magoffin, D.A., 2005. Ovarian theca cell. Int. J. Biochem. Cell Biol. 37,
1344–1349.
Mazaud, S., Guyot, R., Guigon, C.J., Coudouel, N., Le Magueresse-Battistoni,
B., Magre, S., 2005. Basal membrane remodeling during follicle histogen-
esis in the rat ovary: contribution of proteinases of the MMP and PA
families. Dev. Biol. 277, 403–416.
McArthur, M.E., Irving-Rodgers, H.F., Byers, S., Rodgers, R.J., 2000.
Identification and immunolocalization of decorin, versican, perlecan,
nidogen, and chondroitin sulfate proteoglycans in bovine small-antral
ovarian follicles. Biol. Reprod. 63, 913–924.
Mittaz, L., Russell, D.L., Wilson, T., Brasted, M., Tkalcevic, J., Salamonsen,
L.A., Hertzog, P.J., Pritchard, M.A., 2004. Adamts-1 is essential for the
development and function of the urogenital system. Biol. Reprod. 70,
1096–1105.
Mittaz, L., Ricardo, S., Martinez, G., Kola, I., Kelly, D.J., Little, M.H., Hertzog,
P.J., Pritchard, M.A., 2005. Neonatal calyceal dilation and renal fibrosis
resulting from loss of Adamts-1 in mouse kidney is due to a developmental
dysgenesis. Nephrol. Dial. Transplant. 20, 419–423.
Pedersen, T., Peters, H., 1968. Proposal for a classification of oocytes and
follicles in the mouse ovary. J. Reprod. Fertil. 17, 555–557.
Rainey, W.E., Sawetawan, C., McCarthy, J.L., McGee, E.A., Bird, I.M.,
Word, R.A., Carr, B.R., 1996. Human ovarian tumor cells: a potential
model for thecal cell steroidogenesis. J. Clin. Endocrinol. Metab. 81,
257–263.
Richards, J.S., 2005. Ovulation: new factors that prepare the oocyte for
fertilization. Mol. Cell. Endocrinol. 234, 75–79.
Rodgers, R.J., van Wezel, I.L., Irving-Rodgers, H.F., Lavranos, T.C., Irvine,
C.M., Krupa, M., 1999. Roles of extracellular matrix in follicular
development. J. Reprod. Fertil., Suppl. 54, 343–352.
Rodgers, R.J., Irving-Rodgers, H.F., Russell, D.L., 2003. Extracellular matrix of
the developing ovarian follicle. Reproduction 126, 415–424.
709H.M. Brown et al. / Developmental Biology 300 (2006) 699–709Russell, D.L., Doyle, K.M., Ochsner, S.A., Sandy, J.D., Richards, J.S., 2003a.
Processing and localization of ADAMTS-1 and proteolytic cleavage of
versican during cumulus matrix expansion and ovulation. J. Biol. Chem.
278, 42330–42339.
Russell, D.L., Ochsner, S.A., Hsieh, M., Mulders, S., Richards, J.S., 2003b.
Hormone-regulated expression and localization of versican in the rodent
ovary. Endocrinology 144, 1020–1031.
Sandy, J.D., Westling, J., Kenagy, R.D., Iruela-Arispe, M.L., Verscharen, C.,
Rodriguez-Mazaneque, J.C., Zimmermann, D.R., Lemire, J.M., Fischer, J.W.,
Wight, T.N., Clowes, A.W., 2001. Versican V1 proteolysis in human aorta in
vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant
ADAMTS-1 and ADAMTS-4. J. Biol. Chem. 276, 13372–13378.
Shindo, T., Kurihara, H., Kuno, K., Yokoyama, H., Wada, T., Kurihara, Y., Imai,
T.,Wang, Y., Ogata,M., Nishimatsu, H.,Moriyama,N., Oh-hashi, Y.,Morita,
H., Ishikawa, T., Nagai, R., Yazaki, Y.,Matsushima, K., 2000.ADAMTS-1: a
metalloproteinase-disintegrin essential for normal growth, fertility, and organ
morphology and function. J. Clin. Invest. 105, 1345–1352.
Shozu, M., Minami, N., Yokoyama, H., Inoue, M., Kurihara, H., Matsushima,
K., Kuno, K., 2005. ADAMTS-1 is involved in normal follicular
development, ovulatory process and organization of the medullary vascular
network in the ovary. J. Mol. Endocrinol. 35, 343–355.Smith, M.F., Ricke, W.A., Bakke, L.J., Dow, M.P., Smith, G.W., 2002. Ovarian
tissue remodeling: role of matrix metalloproteinases and their inhibitors.
Mol. Cell. Endocrinol. 191, 45–56.
Vittay, P., Bosze, P., Gaal, M., Laszlo, J., 1980. Lymph vessel defects in patients
with ovarian dysgenesis. Clin. Genet. 18, 387–391.
Vollmar, B., Laschke, M.W., Rohan, R., Koenig, J., Menger, M.D., 2001. In vivo
imaging of physiological angiogenesis from immature to preovulatory
ovarian follicles. Am. J. Pathol. 159, 1661–1670.
Vu, T.H., Werb, Z., 2000. Matrix metalloproteinases: effectors of development
and normal physiology. Genes Dev. 14, 2123–2133.
Vu, T.H., Shipley, J.M., Bergers, G., Berger, J.E., Helms, J.A., Hanahan, D.,
Shapiro, S.D., Senior, R.M., Werb, Z., 1998. MMP-9/gelatinase B is a key
regulator of growth plate angiogenesis and apoptosis of hypertrophic
chondrocytes. Cell 93, 411–422.
Wigle, J.T., Oliver, G., 1999. Prox1 function is required for the development of
the murine lymphatic system. Cell 98, 769–778.
Wright, N.B., Carty, H.M., 1994. The swollen leg and primary lymphoedema.
Arch. Dis. Child. 71, 44–49.
Wu, R., Van der Hoek, K.H., Ryan, N.K., Norman, R.J., Robker, R.L., 2004.
Macrophage contributions to ovarian function. Hum. Reprod. Updat. 10,
119–133.
